ALC vs AXSM
Alcon Inc vs Axsome Therapeutics, Inc. — AI-powered side-by-side comparison
VS
AXSM
Axsome Therapeutics, Inc.
55
Watch
| Metric | ALC | AXSM |
|---|
| AI Score |
68
|
55
|
| Price |
$75.39
|
$215.92
|
| P/E Ratio |
45.39×
|
-57.54×
|
| ROE |
4.4%
|
-207.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
93.2%
|
| Debt / Equity |
0.24×
|
2.63×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
41.5
|
| Beta |
0.703
|
0.596
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus AXSM.
ALC leads by 13 points.
ALC scores 68/100 (Buy) versus AXSM at 55/100 (Watch).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
AXSM Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 20.4% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 20.4% signals elevated volatility — Risk